CAS OpenIR  > 中科院上海原子核所2003年前
Na~(123)Ⅰ的临床前药理
王永川; 吉倩梅; 沈德群; 樊法生; 兰云霞; 赵肇懿; 翁守清; 何蔚瑜; 陆介禧; 於新根; 杨兰萍; 张炯; 施锡昌; 李永键; 孙祺薰; 黄天森; 许常渔; 蒋红珠
1984-06-29
Source Publication核技术
Issue06
Abstract<正> ~(123)I核素的核性质较~(131)I更适合于放射性药物设计要求和核医学临床应用;它具有十分优异的医用核性质;有用~(123)I替代~(131)I进行甲状腺显像和功能测定的趋向。其标记的有机化合物;如脂肪酸、β-肾上腺能受体阻断剂、甾体激素等近年已受到放射性药物研究者的重视。我们采用天然锑靶干法成功地生产了Na~(123)I注射液;本文用此注射液观察在其小鼠体内分布;兔甲状腺扫描和γ照相的结果。
Indexed ByCNKI
Language中文
Funding Project原子核所项目组
Document Type期刊论文
Identifierhttp://ir.sinap.ac.cn/handle/331007/10985
Collection中科院上海原子核所2003年前
Recommended Citation
GB/T 7714
王永川,吉倩梅,沈德群,等. Na~(123)Ⅰ的临床前药理[J]. 核技术,1984(06).
APA 王永川.,吉倩梅.,沈德群.,樊法生.,兰云霞.,...&蒋红珠.(1984).Na~(123)Ⅰ的临床前药理.核技术(06).
MLA 王永川,et al."Na~(123)Ⅰ的临床前药理".核技术 .06(1984).
Files in This Item: Download All
File Name/Size DocType Version Access License
Na~(123)Ⅰ的临床前药理.caj(164KB) 开放获取LicenseView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[王永川]'s Articles
[吉倩梅]'s Articles
[沈德群]'s Articles
Baidu academic
Similar articles in Baidu academic
[王永川]'s Articles
[吉倩梅]'s Articles
[沈德群]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[王永川]'s Articles
[吉倩梅]'s Articles
[沈德群]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Na~(123)Ⅰ的临床前药理.caj
Format: Unknown
This file does not support browsing at this time
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.